CREB1-targeting PROTAC compounds for the treatment of Multiple Myeloma
TS-075178 — Problem
Over 30,000 Americans are diagnosed every year with multiple myeloma (MM), a disease of clonal plasma cells which accumulate in the bone marrow. Despite several treatment options, MM is still incurable, and patients inevitably relapse and develop toxicities and functional decline. Novel the…
- College: College of Medicine (COM)
- Inventors: Cottini, Francesca; Cocucci, Emanuele "Ema"
- Licensing Officer: Bhatti, Hamid
